Video

CMSC 2020 Day 1: Peter Calabresi, MD, on CNS Immune Responses in Progressive MS

Author(s):

NeurologyLive® Staff

Peter Calabresi, MD, delivers the Whitaker Lecture as part of the 2020 CMSC Virtual Annual Meeting.

For more coverage from CMSC 2020, click here.

To register for the 2020 CMSC Virtual Annual Meeting, May 26-29, 2020, click here.

To complete the evaluation and claim credit, go to www.highmarksce.com/mscare. Create a new account or log in with your user name and password. Select the Enduring Materials tab, then select the activity from the listing and follow the instructions to complete the activity and receive your credit.

Newsletter

Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.

Subscribe Now!
Related Videos
Cassandra Moore, MPH, CPH
Sam Hooshmand, DO
Funke Afolabi-Brown, MD, FAASM
Brenda L. Wong, MD
Kevin Sheth, MD
Kevin Swong, MD
Related Content
NeuroVoices: Alexander C. Whiting, MD, on Advancing Epilepsy Surgery and Brain Function Research
December 11th 2024

NeuroVoices: Alexander C. Whiting, MD, on Advancing Epilepsy Surgery and Brain Function Research

Alex Whiting, MD Isabella Ciccone, MPH
Identifying Small Clinical Characteristics to Facilitate Early Myasthenia Gravis Diagnosis: Judith Thompson, PharmD, MPH, CPHQ
October 30th 2024

Identifying Small Clinical Characteristics to Facilitate Early Myasthenia Gravis Diagnosis: Judith Thompson, PharmD, MPH, CPHQ

Judith Thompson, PharmD, MPH, CPHQ Marco Meglio
CBD Leads to Nonseizure Improvements, AbbVie Launches 24-Hour Levodopa Infusion in EU, CNM-Au8 Improves Visual Function and Cognition
January 13th 2024

CBD Leads to Nonseizure Improvements, AbbVie Launches 24-Hour Levodopa Infusion in EU, CNM-Au8 Improves Visual Function and Cognition

Marco Meglio
NeuroVoices: Joseph Sullivan, MD, on Exploring Antisense Oligonucleotides for Dravet Syndrome, Rare Epilepsies
September 13th 2023

NeuroVoices: Joseph Sullivan, MD, on Exploring Antisense Oligonucleotides for Dravet Syndrome, Rare Epilepsies

Joseph Sullivan, MD
Zilucoplan Demonstrates Consistent Efficacy in Phase 3 RAISE Study of Generalized Myasthenia Gravis
July 12th 2023

Zilucoplan Demonstrates Consistent Efficacy in Phase 3 RAISE Study of Generalized Myasthenia Gravis

Isabella Ciccone, MPH
Understanding Nuances of Mobile Stroke Units and When to Transfer Directly to Angiography: Shazam Hussain, MD, FRCP, FAHA
February 13th 2023

Understanding Nuances of Mobile Stroke Units and When to Transfer Directly to Angiography: Shazam Hussain, MD, FRCP, FAHA

M. Shazam Hussain, MD, FRCP(C), FAHA
© 2025 MJH Life Sciences

All rights reserved.